RU2001115900A - METHOD FOR TREATING LUNG TUBERCULOSIS - Google Patents
METHOD FOR TREATING LUNG TUBERCULOSISInfo
- Publication number
- RU2001115900A RU2001115900A RU2001115900/14A RU2001115900A RU2001115900A RU 2001115900 A RU2001115900 A RU 2001115900A RU 2001115900/14 A RU2001115900/14 A RU 2001115900/14A RU 2001115900 A RU2001115900 A RU 2001115900A RU 2001115900 A RU2001115900 A RU 2001115900A
- Authority
- RU
- Russia
- Prior art keywords
- treating lung
- lung tuberculosis
- tuberculosis
- treating
- bestim
- Prior art date
Links
- 210000004072 Lung Anatomy 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
- CATMPQFFVNKDEY-AAEUAGOBSA-N (2S)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)CC[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 CATMPQFFVNKDEY-AAEUAGOBSA-N 0.000 claims 1
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Claims (1)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2001115900/14A RU2229892C2 (en) | 2001-06-08 | 2001-06-08 | Method for treatment of pulmonary tuberculosis |
PCT/US2001/048560 WO2003013572A1 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
US10/485,487 US7173013B2 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
EP09000806A EP2078525A3 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
EP01271057A EP1420808A4 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis using immunomodulator compounds |
JP2003518578A JP4837251B2 (en) | 2001-06-08 | 2001-12-20 | Treatment of tuberculosis with immunomodulatory compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2001115900/14A RU2229892C2 (en) | 2001-06-08 | 2001-06-08 | Method for treatment of pulmonary tuberculosis |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001115900A true RU2001115900A (en) | 2003-03-10 |
RU2229892C2 RU2229892C2 (en) | 2004-06-10 |
Family
ID=20250617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001115900/14A RU2229892C2 (en) | 2001-06-08 | 2001-06-08 | Method for treatment of pulmonary tuberculosis |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP1420808A4 (en) |
JP (1) | JP4837251B2 (en) |
RU (1) | RU2229892C2 (en) |
WO (1) | WO2003013572A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2450820C2 (en) * | 2010-07-20 | 2012-05-20 | Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) | Method of treating destructive pulmonary tuberculosis |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005112639A2 (en) * | 2004-05-14 | 2005-12-01 | Sciclone Pharmaceuticals, Inc. | Treatment or prevention of respiratory viral infections with immunomodulator compounds |
WO2006116053A1 (en) * | 2005-04-22 | 2006-11-02 | Sciclone Pharmaceuticals, Inc. | Immunomodulator compounds as vaccine enhancers |
NZ579570A (en) | 2007-02-13 | 2012-02-24 | Sciclone Pharmaceuticals Inc | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
WO2009025830A1 (en) * | 2007-08-23 | 2009-02-26 | Sciclone Pharmaceuticals, Inc. | Treatment of lung cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4520196A (en) * | 1983-08-18 | 1985-05-28 | American Home Products Corporation | α-Mercaptophenylacetic acid derivatives of imidazole-containing compounds and analogues thereof |
US5212192A (en) * | 1989-11-24 | 1993-05-18 | Janssen Pharmaceutica N.V. | Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives |
WO1994020063A2 (en) * | 1993-03-04 | 1994-09-15 | Cytoven International N.V. | Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof |
US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
WO1997019691A1 (en) * | 1995-11-28 | 1997-06-05 | Wei, Edward, T. | Gamma-l-glutamyl containing immunomodulator compounds and methods therewith |
DE69620233T2 (en) * | 1995-12-14 | 2002-11-14 | Novelos Therapeutics Inc | OXIDIZED GLUTATHION AS A MEANS TO IMPROVE THE ENDOGENIC PRODUCTION OF CYTOKINES AND HAEMATOPOIETIC FACTORS |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
-
2001
- 2001-06-08 RU RU2001115900/14A patent/RU2229892C2/en not_active IP Right Cessation
- 2001-12-20 JP JP2003518578A patent/JP4837251B2/en not_active Expired - Fee Related
- 2001-12-20 EP EP01271057A patent/EP1420808A4/en not_active Withdrawn
- 2001-12-20 EP EP09000806A patent/EP2078525A3/en not_active Withdrawn
- 2001-12-20 WO PCT/US2001/048560 patent/WO2003013572A1/en active Application Filing
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2450820C2 (en) * | 2010-07-20 | 2012-05-20 | Государственное учреждение "Научно-практический центр "Фтизиатрия" Министерства здравоохранения республики Саха (Якутия) | Method of treating destructive pulmonary tuberculosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2017047I1 (en) | Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, including citrate salt | |
NO2020007I1 (en) | Sitagliptin, optionally in the form of a pharmaceutically acceptable salt | |
NO20041277L (en) | Pharmaceutical preparations for the treatment of asthma. | |
AU2001276952A1 (en) | Method of treating the syndrome of coronary heart disease risk factors in humans | |
ITRE20000134A0 (en) | METHOD AND DEVICE FOR THE DIAGNOSIS AND THERAPY OF CHRONIC HEART FAILURE. | |
JP2004504381A5 (en) | ||
CY2009017I1 (en) | METHOD FOR THE PREPARATION OF 10, 11-DIHYDRO-10-HYDROXY-5H-DIBENZO/B,F/AZEPINO-5-CARBOXAMIDE AND 10,11-DIHYDRO-10-OXO-5H-DIBENZO/B,F/AZEPINO-5- CARBOXAMIDE | |
ATE303386T1 (en) | THE CITRATE SALT OF 5,8,14,- TRIAZATETRACYCLO(10.3.1.02,11.04,9)-HEXADECA-2(11),3,5,7,9-PENTAENE | |
NO20014648D0 (en) | Compounds and methods for the treatment of asthma, allergies and inflammatory diseases | |
EP1448185A4 (en) | Treating asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties | |
RU2001115900A (en) | METHOD FOR TREATING LUNG TUBERCULOSIS | |
ZA200104616B (en) | Diazepinoindoles for the treatment of chronic obstructive pulmonary disease. | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
WO2002036163A3 (en) | Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses | |
RU98114654A (en) | METHOD FOR TREATING LUNG TUBERCULOSIS | |
RU2002133917A (en) | METHOD FOR TREATING LUNG TUBERCULOSIS | |
RU2001129920A (en) | The method of phage therapy of tuberculosis | |
RU2000110723A (en) | METHOD FOR TREATING LUNG TUBERCULOSIS WITH A PREFERREDLY PRODUCTIVE TYPE OF TISSUE REACTION | |
EP1364578A4 (en) | Schizophrenia-like mental disease model animal, method of constructing the same and use thereof | |
ITRM20010332A0 (en) | SUBUNITY VACCINES AND PROCEDURES FOR THEIR PRODUCTION. | |
RU2002113730A (en) | A method for the treatment of chronic obstructive pulmonary disease | |
RU2002103016A (en) | A method for the surgical treatment of pulmonary tuberculosis | |
RU2001120480A (en) | A method of preparing a patient for fibrobronchoscopy | |
RU98102431A (en) | METHOD FOR TREATMENT OF PULMONARY PULMONARY DISEASES | |
RU99114895A (en) | METHOD FOR TREATING ACUTE PROGRESSING LUNG TUBERCULOSIS |